for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Smiths Group plc

SMIN.L

Latest Trade

1,456.00GBp

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

1,347.50

 - 

1,669.50

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
1,456.00
Open
--
Volume
--
3M AVG Volume
16.24
Today's High
--
Today's Low
--
52 Week High
1,669.50
52 Week Low
1,347.50
Shares Out (MIL)
395.89
Market Cap (MIL)
5,738.43
Forward P/E
16.79
Dividend (Yield %)
2.60

Next Event

Half Year 2022 Smiths Group PLC Earnings Release

Latest Developments

More

Smiths Group Says Qtrly Cont Ops Revenue Was Up 1% On An Underlying Basis

Japan Customs And Smiths Detection To Boost Surveillance With State-Of-The-Art Inspection System

Smiths Group FY Revenue Falls To 2,406 Mln Stg

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Smiths Group plc

Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Detection, Flex-Tek, Smiths Interconnect and Smiths Medical. John Crane provides mission-critical solutions such as mechanical seals, seal support systems, power transmission couplings and filtration systems for global energy and process industries. Smiths Detection produces detection and screening technologies for the identification of safety and security threats. Flex-Tek provides engineered components that heat and move fluids and gases for aerospace, consumer products, construction, medical and industrial applications. Smiths Interconnect provides electronic components, subsystems, microwave and radio frequency products that provide secure connectivity of critical applications in the defense, aerospace, communications and industrial markets. Smiths Medical offers medical devices and consumables in the select segments of the infusion systems, vascular access and vital care markets.

Industry

Misc. Capital Goods

Contact Info

4th Fl, 11-12 St. James's Square

SW1Y 4LB

United Kingdom

+44.20.70041600

https://www.smiths.com/

Executive Leadership

George W. Buckley

Non-Executive Independent Chairman of the Board

Paul A. Keel

Chief Executive Officer, Executive Director

John Francis Shipsey

Chief Financial Officer, Executive Director

Roland Carter

President, Smiths Detection and Asia Pacific

Julian Fagge

President - Smiths Interconnect

Key Stats

2.10 mean rating - 10 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2019

2.5K

2020

2.5K

2021

2.4K

2022(E)

2.5K
EPS (GBp)

2019

96.100

2020

84.200

2021

92.600

2022(E)

86.308
Price To Earnings (TTM)
37.02
Price To Sales (TTM)
2.39
Price To Book (MRQ)
2.39
Price To Cash Flow (TTM)
19.39
Total Debt To Equity (MRQ)
62.16
LT Debt To Equity (MRQ)
61.03
Return on Investment (TTM)
3.60
Return on Equity (TTM)
2.92

Latest News

Latest News

FTSE 100 flat as mining stocks weigh; Smiths Group top gainer

London's FTSE 100 was subdued on Tuesday as losses in mining heavyweights outweighed strength in energy shares, while Smiths Group topped the blue-chip index after the technology company delivered positive full-year results.

UK's Smiths to sell medical division to ICU for $2.4 billion, snubs TA

British industrial technology group Smiths has agreed to sell its medical division to U.S.-based ICU Medical for $2.4 billion, it said on Wednesday, scrapping an earlier $2 billion deal with private equity firm TA Associates.

Britain's Smiths Group to sell medical unit in $2.3 billion deal

British engineering and technology company Smiths Group said on Monday it will sell its medical unit for $2.3 billion including debt to U.S. private equity firm TA Associates as it focuses on its core industrial technology business.

Smiths Group breakup saga may end with a whimper

(The author is a Reuters Breakingviews columnist. The opinions expressed are their own.)

TA Associates makes $2.8 billion takeover approach for Smiths Group unit: Mail on Sunday

U.S. private equity firm TA Associates has made a 2 billion pounds ($2.78 billion) takeover approach for the medical division of Smiths Group Plc, which makes ventilators for hospitals, the Mail on Sunday reported https://bit.ly/3e9oIuF.

UPDATE 1-UK's Smiths Group appoints former 3M executive as new CEO

Britain's Smiths Group Plc said on Tuesday it has appointed Paul Keel as its new chief executive officer as the technology company braces for a next growth phase following a long-sought separation of its medical unit.

UK's Smiths Group names new CEO

Britain's Smiths Group Plc said on Monday it has appointed Paul Keel as its new chief executive officer.

CORRECTED-UPDATE 1-Engineer Smiths expects to meet full-year market view after profit beat

Smiths Group said on Friday it expects to meet market expectations for the fiscal year, as the British engineering firm forecast improving trends for the current half on the back of better-than-estimated interim profit.

Engineering firm Smiths Group sees better second half after profit beat

Smiths Group on Friday forecast improving trends for the second half of the fiscal year after the British engineering firm reported a better-than-expected profit and added that it was on track to separate its medical unit by the fourth quarter.

CORRECTED-Smiths Group annual profit falls

Smiths Group reported a 26% fall in annual operating profit on Thursday due to higher costs and a hit from the COVID-19 pandemic, while the British engineering firm also said it was cutting jobs as part of its restructuring plan.

Engineering firm Smiths plans job cuts after annual profit falls

Smiths Group <SMIN.L> reported a lower annual profit on Thursday due to higher costs and a hit from the COVID-19 pandemic, while the British engineering firm also said it would cut jobs as part of its restructuring plan.

BRIEF-Smiths Detection Partners With Attomarker To Develop Triple Antibody Testing Device For Covid-19

* SMITHS DETECTION ANNOUNCES PARTNERSHIP WITH ATTOMARKER IN THE DEVELOPMENT OF A TRIPLE ANTIBODY TESTING DEVICE FOR COVID-19

Smiths to help make blood-based coronavirus test in Britain

Smiths Group <SMIN.L> will help produce a blood-based COVID-19 antibody test approved by Britain's healthcare regulator in the firm's latest involvement in tackling the coronavirus.

UK tech firm Smiths Group to help make COVID-19 antibody test

Britain's Smiths Group on Wednesday said it would help produce a blood-based COVID-19 antibody test approved by the country's regulators, another move by the technology firm to develop products to combat the pandemic.

Smiths halts medical unit split to focus on ventilator production

UK's Smiths Group <SMIN.L> said on Tuesday the separation of its medical unit will be delayed, as it focuses on making and delivering ventilators and critical-care devices to hospitals tackling the shortage of life-saving equipment as the coronavirus spreads.

Smiths halts medical unit split to focus on ventilator production

UK's Smiths Group said on Tuesday the separation of its medical unit will be delayed, as it focuses on making and delivering ventilators to hospitals tackling the shortage of life-saving equipment as the coronavirus spreads.

BRIEF-Smiths Group Delays Smiths Medical Separation; Sees Weaker Demand

* SMITHS GROUP - ANNOUNCES A DELAY TO SEPARATION OF SMITHS MEDICAL

BRIEF-Smiths Group Delays Publication Of Its Interim Financial Results

* SMITHS GROUP PLC - FCA MORATORIUM ON PUBLICATION OF RESULTS

BRIEF-Smiths Group Significantly Ramping Up Weekly Production Of Ventilators

* PRESS RELEASE - SMITHS GROUP SIGNIFICANTLY RAMPING UP WEEKLY PRODUCTION OF VENTILATORS

UK's Smiths Group chief likely to step down next year -report

Smiths Group Plc's Chief Executive Andy Reynolds Smith will likely step down next year after a demerger of its medical unit, the Sunday Times reported.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up